Condition
Breast Neoplasm Malignant Primary
Total Trials
5
Recruiting
2
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Recruiting2
Completed2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06257888CompletedPrimary
A Prospective Cohort With Patient Navigation as an Intervention for Breast Cancer Patients
NCT06310330Not ApplicableRecruitingPrimary
TRUST-ACE - Anticancer-treatment Cardiotoxicity Identification by Echocardiography
NCT06505577Recruiting
Preoperative vs. Pathologic Size in Breast Cancer: A Prospective Study
NCT03602079Phase 1Completed
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
NCT02949310Not ApplicableUnknownPrimary
Effectiveness of Nefopam in Breast Cancer Surgery
Showing all 5 trials